Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload

BMC Nephrology

Volumn 2, Issue , 2001, Pages 1-6

  Johnson, David Wayne ^a   Arndt, Mary ^a   O'Shea, Amanda ^a   Watt, Rhonda ^a   Hamilton, Jan ^a   Vincent, Kaia ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EXTRANEAL; GLUCOSE; ICODEXTRIN; LOOP DIURETIC AGENT; SERUM ALBUMIN; DIALYSIS FLUID; GLUCAN;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIALYSATE; DRUG ERUPTION; FEMALE; FLUID RETENTION; HAZARD ASSESSMENT; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; PERITONITIS; PLASMA; SALVAGE THERAPY; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SURVIVAL; ULTRAFILTRATION; HEMODIAFILTRATION; METABOLIC DISORDER; METHODOLOGY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY;

DIALYSIS SOLUTIONS; FEMALE; GLUCANS; GLUCOSE; HEMODIAFILTRATION; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SALVAGE THERAPY; WATER-ELECTROLYTE IMBALANCE;

EID: 3142546249     PISSN: 14712369     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-2-1     Document Type: Article

References (24)

1. Mistry CD, Gokal R, Peers E: A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 1994, 46:496-503
2. Posthuma N, ter Wee PM, Verbrugh HA, Oe PL, Peers E, Sayers J, et al: Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance. Nephrol Dial Transplant 1997, 12:550-553
3. Ho-dac-Pannekeet MM, Schouten N, Langendijk MJ, Hiralall JK, de Waart DR, Struijk DG, et al: Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996, 50:979-986
4. Woodrow G, Stables G, Oldroyd B, Gibson J, Turney JH, Brownjohn AM: Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis. Nephrol Dial Transplant 1999, 14:1530-1535
5. Krediet RT, Ho-dac-Pannekeet MM, Imholz AL, Struijk DG: Icodextrin's effects on peritoneal transport. Pent Dial Int 1997, 17:35-41
6. Coles GA: Biocompatibility and new fluids. Pent Dial Int 1999, 19 Suppl 2:S267-70
7. Peers EM, Scrimgeour AC, Haycox AR: Cost-containment in CAPD patients with ultrafiltration failure. Clin Drug Invest 1995, 10:53-58
8. Wilkie ME, Plant MJ, Edwards L, Brown CB: Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival. Perit Dial Int 1997, 17:84-87
9. Twardowski ZJ: PET - a simpler approach for determining prescriptions for adequate dialysis therapy. Adv Perit Dial 1990, 6:186-191
10. Davies SJ: Monitoring of long-term peritoneal membrane function. Perit Dial Int 2001, 21:225-230
11. Imholz AL, Brown CB, Koomen GC, Arisz L, Krediet RT: The effect of glucose polymers on water removal and protein clearances during CAPD. Adv Perit Dial 1993, 9:25-30
12. Heimburger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990, 38:495-506
13. Krediet RT, Imholz AL, Struijk DG, Koomen GC, Arisz L: Ultrafiltration failure in continuous ambulatory peritoneal dialysis. Perit Dial Int 1993, 13 Suppl 2:S59-66
14. Mujais S, Nolph K, Gokal R, Blake P, Burkart J, Coles G, et al: Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Pent Dial Int 2000, 20 Suppl 4:S5-21
15. Disney APS, Russ GR, Walker R, Collins J, Herberrt K, Kerr P: Twenty-second Annual Report of the Australian and New Zealand Dialysis and Transplant Registry. Adelaide: Australian and New Zealand Dialysis and Transplant Registry; 1999
16. Davies SJ, Phillips L, Naish PF, Russell GI: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001, 12:1046-1051
17. Posthuma N, ter Weel PM, Donker AJ, Peers EM, Oe PL, Verbrugh HA: Icodextrin use in CCPD patients during peritonitis: ultrafiltration and serum disaccharide concentrations. Nephrol Dial Transplant 1998, 13:2341-2344
18. Posthuma N, ter Wee PM, Donker AJ, Oe PL, Peers EM, Verbrugh HA: Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group. Perit Dial Int 2000, 20 Suppl 2:S106-S113
19. Breborowicz a, Oreopoulos DG: Biocompatibility of peritoneal dialysis solutions. Am J Kidney Dis 1996, 27:738-743
20. Tzamaloukas AH, Murata GH, Malhotra D, Rao P, Piraino B, Bernardini J, et al: Small-solute clearances in diabetic subjects on continuous ambulatory peritoneal dialysis: comparison to nondiabetic subjects. Adv Perit Dial 1999, 15:179-182
21. Cueto Manzano AM, Correa Rotter R: Is high peritoneal transport rate an independent risk factor for CAPD mortality? Kidney Int 2000, 57:314-320
22. Kjellstrand C, Hylander B, Collins A: Mortality on dialysis: on the influence of early start, patient characteristics, and transplantation and acceptance rates. Perit Dial Int 1999, 19:483-490
23. Hung KY, Lin TJ, Tsai TJ, Chen WY: Impact of peritoneal membrane transport on technique failure and patient survival in a population on automated peritoneal dialysis. ASAIO J 1999, 45:568-573
24. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998, 9:1285-1292